Skip to main content

Publication

Home | Improvement in exercise duration, lung function and well-being in G551D-cystic Fibrosis patients: a double-blind, placebo-controlled, randomised, cross-over study with ivacaftor treatment.
Improvement in exercise duration, lung function and well-being in G551D-cystic Fibrosis patients: a double-blind, placebo-controlled, randomised, cross-over study with ivacaftor treatment.
Dominic T Keating, Deirdre Edgeworth, Matthew Ellis, Brenda Button, Elyssa Williams, Denise Clark, Audrey Tierney, Stephane Heritier, Anastase Kotsimbos, John Wilson
(2017)
Improvement in exercise duration, lung function and well-being in G551D-cystic Fibrosis patients: a double-blind, placebo-controlled, randomised, cross-over study with ivacaftor treatment. in Clinical Science